Biology of Disease

Biology of Disease

Volumn , Issue , 2007, Pages 1-550

  Ahmed, Nessar ^a   Dawson, Maureen ^a   Smith, Chris ^a   Wood, Ed ^b  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85127965633     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9780203504727     Document Type: Book

References (333)

1. Henny, J and Hyltoft Petersen, P (2004) Reference values: from philosophy to a tool for laboratory medicine. Clin. Chem. Lab. Med. 42: 686-691.
2. Hooper, J, McCreanor, G, Marshall, W and Myers, P (1996) Primary Care and Laboratory Medicine. ACB Venture Publications, Cambridge.
3. Irjala, KM and Gronroos, PE (1998) Preanalytical and analytical factors affecting laboratory results. Ann. Med. 30: 267-272.
4. Khan, KS, Dinnes, J and Klijnen, J (2001) Systematic reviews to evaluate diagnostic tests. Eur. J. Obstet. Gynecol. Reprod. Biol. 95: 6-11.
5. Libeer, J-C (2001) Role of external quality assurance schemes in assessing and improving quality in medical laboratories. Clin. Chim. Acta 309: 173-177.
6. Moyer, VA and Kennedy, KA (2003) Understanding and using diagnostic tests. Clin. Perinatol. 30: 189-204.
7. Stewart, A (2002) Basic Statistics and Epidemiology. Radcliffe Medical Press, UK.
8. Stolley, PD and Lasky, T (1998) Investigating Disease Patterns. Scientific American Library, NY.
9. Thagard, P (1996) The concept of disease: structure and change. Commun. Cogn. 29: 445-478.
10. Wachel, M, Paulson, R and Plese, C (1996) Creation and verification of reference intervals. Lab. Med. 26: 593-597.
11. Weinstein, S, Obuchowski, NA and Lieber, ML (2005) Clinical evaluation of diagnostic tests. Am. J. Roentgenol. 185: 14-19.
12. Alouf, JE and Freer, JH (eds) (1999) The Comprehensive Sourcebook of Bacterial Protein Toxins, 2nd edn, Academic Press, London.
13. Braun, V and Killman, H (1999) Bacterial solutions to the iron supply problem. Trends Biochem. Sci. 24: 104-109.
14. Caughey, B (2001) Interactions between prion protein isoforms: the kiss of death? Trends Biochem. Sci. 26: 235-242.
15. DeArmond, SJ and Bouzamondo, E (2002) Fundamentals of prion biology and diseases. Toxicology 181-182: 9-16.
16. Deitsch, KW, Moxon, ER and Wellems, TE (1997) Shared themes of antigenic variation and virulence in bacterial, protozoal and fungal infections. Microbiol. Mol. Biol. Rev. 61: 281-293.
17. Finlay, BB and Falkow, S (1989) Common themes in microbial pathogenicity. Microbiol. Rev. 53: 210-230.
18. Glatzel, M, Stoeck, K, Seeger, H, Luhrs, T and Aguzzi, A (2005) Human prion diseases: molecular and clinical aspects. Arch. Neurol. 62: 545-552.
19. Greenwood, BM, Bojang, K, Whitty, CJ and Targett, CA (2005) Malaria. Lancet 365: 1487-1498.
20. Irving, W, Boswell, T and Ala' Aldeen, D (2005) Instant Notes on Medical Microbiology, BIOS/Taylor and Francis, London, UK.
21. Jedrzejas, MJ (2001) Pneumococcal virulence factors: structure and function. Microbiol. Mol. Biol. Rev. 65: 187-207.
22. Jerse, AE and Rest, RF (1997) Adhesion and invasion by the pathogenic neisseria. Trends Microbiol. 5: 217-221.
23. Maitland, K, Bejon, P and Newton, CRJC (2003) Malaria. Curr. Opin. Infect. Dis. 16: 389-395.
24. Perry, RD and Fetherston, JD (1997) Yersinia pestis-etiologic agent of plague. Clin. Microbiol. Rev. 10: 35-66.
25. Sears, CK and Kaper, JB (1996) Bacterial toxins: mechanisms of action and linkage to intestinal secretions. Microbiol. Rev. 60: 167-215.
26. Smith, AE and Helenius, A (2004) How viruses enter animal cells. Science 304: 237-242.
27. Spicer, JW (2000) Clinical Bacteriology, Mycology and Parasitology, Churchill Livingstone, London, UK.
28. Turton, K, Chaddock, JA and Acharya, KR (2002) Botulinum and tetanus neurotoxins: structure, function and therapeutic utility. Trends Biochem. Sci. 27: 552-558.
29. Abraham, SN, Jonsson, A-B and Normark, S (1998) Fimbriae-mediated hostpathogen cross-talk. Curr. Opin. Microbiol. 1: 75-81.
30. Abuhammour, W and Habte-Gaber, E (2004) Newer antifungal agents. Indian J. Pediatr. 71: 253-259.
31. Andrews, TM (2003) Current concepts in antibiotic resistance. Curr. Opin. Otolaryngol. Head Neck Surg. 11: 409-415.
32. Barrett, B, Ebah, L and Roberts, IS (2002) Genomic structure of capsular determinants. Curr. Top. Microbiol. Immunol. 1: 137-155.
33. Chakraborty, C, Nandi, S and Jana, S (2005) Prion disease: a deadly disease for protein misfolding. Curr. Pharm. Biotechnol. 6: 167-177.
34. Chambers, HF (2003) Solving staphylococcal resistance to ??-lactams. Trends Microbiol. 11: 135-148.
35. Frayha, GI, Smyth, ID, Gobert, JG and Savel, J (1997) The mechanisms of action of antiprotozoal and anthelmintic drugs in man. Gen. Pharmacol. 28: 273-299.
36. Frieden, TR, Sterling, TR, Munsiff, SS, Watt, CJ and Dye, C (2003) Tuberculosis. Lancet 362: 887-899.
37. Gould, D (2004) Bacterial infections: antibiotics and decontamination. Nurs. Stand. 18: 38-42.
38. Hagan, P, Projan, S and Rosamond, J (2002) Infectious diseases: back to the future? Trends Microbiol. 10: S1-S2.
39. Hayden, FG (2006) Antiviral resistance in influenza viruses-Implications for management and pandemic response. N. Engl. J. Med. 354: 785-788.
40. Krcmery, VC (2005) Antifungal chemotherapeutics. Med. Princ. Pract. 14: 125-135.
41. Lipsitich, M (2001) The rise and fall of antimicrobial resistance. Trends Microbiol. 9: 438-444.
42. Papageorgiou, AC and Acharya, KR (2000) Microbial superantigens: from structure to function. Trends Microbiol. 8: 369-375.
43. Prinz, C, Hafsi, N and Voland, P (2003) Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination. Trends Microbiol. 11: 134-138.
44. Prusiner, SB (2003) Prion Biology and Diseases. University of California, USA.
45. Putman, M, van Veen, HW and Konings, WN (2000) Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64: 672-693.
46. Razin, S, Yogev, D and Naot, Y (1998) Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 62: 1094-1156.
47. Rhen, M, Eriksson, S, Clements, M, Bergström, S and Normark, J (2003) The basis of persistent bacterial infections. Trends Microbiol. 11: 80-86.
48. Rover, JK, Vats, V, Uppal, G and Yadav, S (2001) Anthelmintics: a review. Trop. Gastroenterol. 22: 180-189.
49. Seeger, C and Mason, WS (2000) Hepatitis B virus biology. Microbiol. Mol. Biol. Rev. 64: 51-68.
50. Sharma, R, Sharma, CL and Kapoor, B (2005) Antibacterial resistance: current problems and possible solutions. Indian J. Med. Sci. 59: 120-129.
51. Smith, MA (2005) Antibiotic resistance. Nurs. Clin. North Am. 40: 63-75.
52. Stebbing, JS, Gazzard, B and Douek, DC (2004) Where does HIV live? N. Engl. J. Med. 350: 1872-1880.
53. Stephans, RS (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 11: 44-51.
54. White, TC, Marr, KA and Bowden, RA (1998) Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11: 382-400.
55. Yang, S and Rothman, RE (2004) PCR-based diagnostics for infectious diseases; uses, limitations, and future applications in acute-care settings. Lancet Infect. Dis. 4: 337-348.
56. Alonso, PL, Sacarial, J, Aponte, JJ et al. (2004) Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364: 1411-1420.
57. Carroll, MC (2004) The complement system in regulation of adaptive immunity. Nature Immunol. 5: 981-986.
58. Ceciliani, F, Giordano, A and Spagnolo, V (2002) The systemic reaction during inflammation: the acute phase proteins. Protein Pept. Lett. 9: 211-223.
59. Chapel, H, Haeney, M, Misbah, S and Snowden, N (1999) Essentials of Clinical Immunology, 4th edn. Blackwell Science, Oxford, UK.
60. Helm, T (2004) Basic immunology: a primer. Minn. Med. 87: 40-44.
61. Hyatt, MA (2002) Microscopy, Immunohistochemistry, and Antigen Retrieval Methods for Light and Electron Microscopy. Kluwer Academic/Plenum Publishers, New York, USA.
62. Jack, DL and Turner, MW (2003) Anti-microbial activities of mannose binding lectin. Biochem. Soc. Trans. 31: 753-757.
63. Jackson, DC, Purcell, AW, Fitzmaurice, CJ, Zeng1, W and Hart, DNJ (2002) The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer. Curr. Drug Targets 3: 175-196.
64. Kärre, K and Colonna, M (Editors) (1998) Specificity, function, and development of NK cells: NK cells: the effector arm of innate immunity. Curr. Top. Microbiol. Immunol. 230, contains a number of interesting articles.
65. King, DJ (1998) Applications and Engineering of Monoclonal Antibodies. Taylor and Francis, London, UK.
66. Laroux, FS (2004) Mechanisms of inflammation: the good, the bad and the ugly. Front. Biosci. 9: 3156-3162.
67. Pestka, S, Krause, CD and Walter, MR (2004) Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202: 8-32.
68. Price, CP and Newman, DJ (2001) Principles and Practice of Immunoassay. Macmillan, UK.
69. Todd, I and Spickett, G (2005) Lecture Notes on Immunology, 5th edn., Blackwell Science, Oxford, UK.
70. Vladutiu, AO (2000) Immunoglobulin D: Properties, measurement and clinical relevance. Curr. Diagn. Lab. Immunol. 7: 131-140.
71. Chapel, H, Haeney, M, Misbah, S and Snowden, N (1999) Essentials of Clinical Immunology, 4th edn. Blackwell Science Ltd, Oxford.
72. Chinen, J and Shearer, WT (2003) Basic and clinical immunology. J. Allergy Clin. Immunol. 111: S813-S818.
73. Conley, ME, Rohrer, J and Minegishi, Y (2000) X-linked agammaglobulinemia. Clin. Rev. Allergy Immunol. 19: 183-204.
74. Di Renzo, M, Pasqui, AL and Auteri, A (2004) Common variable immunodeficiency; a review. Clin. Exp. Immunol. 3: 211-217.
75. Etzioni, A (2003) Immune deficiency and autoimmunity. Autoimmun. Rev. 2: 364-369.
76. Fischer, A, Hacein-Bey, S, Le Diest, F et al. (2001) Gene therapy for human severe combined immunodeficiencies. Immunity 15: 1-4.
77. Goldsby, RA, Kindt, TJ, Osborne, BA and Kuby, J (2003) Immunology, 5th edn. W.H. Freeman and Co., New York, USA.
78. Heyworth, PG, Cross, AR and Curnutte, JT (2003) Chronic granulomatous disease. Curr. Opin. Immunol. 15: 578-584.
79. Ismail, AA and Snowden, N (1999) Autoantibodies and specific serum proteins in the diagnosis of rheumatological disorders. Ann. Clin. Biochem. 36: 565-578.
80. Lekstrom-Himes, JA and Gallin, JI (2000) Advances in Immunology: immunodeficiency diseases caused by defects in phagocytes. New Engl. J. Med. 343: 1703-1714.
81. Mancias, C, Infante, AJ and Kamani, NR (1999) Matched unrelated donor bone marrow transplantation in leukocyte adhesion deficiency. Bone Marrow Transplant 24: 1261-1263.
82. Notarangelo, L, Casanova, J-L, Fischer, A, Puck, J, Rosen, F, Seger, R and Geha, R (2004) Primary Immunodeficiency disease: an update. J. Allergy Clin. Immunol. 114: 677-687.
83. Todd, I and Spickett, G (2005) Lecture notes: Immunology, 5th edn, Blackwell Science, Oxford.
84. Turner, MW (2003) The role of mannose-binding lectin in health and disease. Molec. Immunol. 40: 423-429.
85. Wen, L, Atkinson, JP and Giclas, PC (2004) Clinical and laboratory evaluation of complement deficiency. J. Allergy Clin. Immunol. 113: 585-593.
86. Avent, ND and Reid, ME (2000) The Rh blood group system: a review. Blood 95: 375-387.
87. Basara, N, Blau, WI, Kiehl, MG, Schmetzer, B, Bischoff, M, Kirsten, D, Günzelmann, S and Fauser, AA (2000) Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients. Clin. Transplant. 14(2): 121-126.
88. Daniels, GL, Cartron, JP, Fletcher, A, Garratty, G, Henry, S, Jorgenson, J, Judd, WJ, Levene, C, Lin, M, Lomas-Francis, C, Moulds, JJ, Moulds, JM, Overbeeke, M, Reid, ME, Rouger, P, Scott, M, Sistonen, P, Smart, E, Tani, Y, Wendel, S and Zelinski, T (2003) ISBT Committee on Terminology for Red Cell Surface Antigens. Vancouver Report. Vox Sang 84: 244-247.
89. Dyer, P and Middleton, D (eds) (1993) Histocompatibility testing: a practical approach. IRL Press, Oxford.
90. Edgar, J and David, M (2006) Master medicine immunology: A core text with self-assessment. Churchill Livingstone, Edinburgh.
91. Elmaagacli, AH, Peceny, R, Steckel, N, Trenschel, R, Ottinger, H, Gross-Wilde, H, Schaefer, UW and Beelen, DW (2003) Outcome of transplantation of highly purified blood CD34+ cells with T-cell add-back compared with unmanipulated bone marrow or peripheral blood stem cells from HLA-identical sibling donors in patients with first chronic phase myeloid leukaemia. Blood 101: 446-453.
92. Ginns, LC, Cosimi, AB and Morris, PJ (1999) Immunosuppression in Transplantation. Blackwell Science, Malden, MA, USA.
93. Hill, B (2004) Transfusion science: Aiming for safety. Med. Lab. World http://www.mlwmagazine.com
94. Hughes-Jones, NC (2002) Historical review: Red cell agglutination: the first description by Creite (1869) and further observations made by Landois (1875) and Landsteiner (1901). Br. J. Haematol. 119: 889-893.
95. Kjellstrom, BT (2003) Blood substitutes: where do we stand today? J. Int. Med. 253: 495-497.
96. Kopko, M and Holland, PV (1999) Transfusion related acute lung injury. Br. J. Haematol. 105: 322-329.
97. Lee, AH and Reid, ME (2000) ABO Blood group system: a review of molecular aspects. In Immunohematology 16: 1-6 Special Millennium Issue.
98. Llewellyn, CA, Hewitt, PE, Knight, RSG, Amar, K, Cousens, S, Mackenzie, J and Will, RG (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363: 417-421.
99. Lomas-Francis, C and Reid, ME (2000) The Rh blood group system: the first 60 years of discovery. In Immunohematology 16: 7-17 Special Millennium Issue.
100. Palfi, M, Berg, S, Ernerudh, J and Berlin, G (2001) A randomised controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 41: 317-322.
101. Schwartz, HP (2003) Historical Review: Karl Landsteiner and his major contributions to haematology. Br. J. Haematol. 121: 556-565.
102. Ahmed, N (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract. 67: 3-21.
103. Ali, I and Dawber, R (2004) Hirsutism: diagnosis and management. Hosp. Med. 65: 293-297.
104. Ben-Shlomo, A and Melmed, S (2001) Acromegaly. Endocrinol. Metab. Clin. North Am. 30: 565-583.
105. Boscaro, M, Barzon, L, Fallo, F and Sonino, N (2001) Cushing's syndrome. Lancet 357: 783-791.
106. Carroll, MF, Burge, MR and Schade, DS (2003) Severe hypoglycemia in adults. Rev. Endoc. Metab. Disord. 4: 149-157.
107. Cornia, PB and Anawalt, BD (2004) Male hormonal contraception. Expert Opin. Emerg. Drugs 9: 335-344.
108. Dattani, M and Preece, M (2004) Growth hormone deficiency and related disorders: insights into causation, diagnosis and treatment. Lancet 363: 1977-1987.
109. Ehrmann, DA (2005) Polycystic ovary syndrome. N. Engl. J. Med. 352: 1223- 1236.
110. Erxheimer, A and Waterhouse, J (2003) The prevention and treatment of jet lag. BMJ 326: 296-297.
111. Holdaway, IM (2004) Treatment of acromegaly. Horm. Res. 62: 79-92.
112. Kaufman, FR (2003) Type I diabetes mellitus. Pediatr. Rev. 24: 291-299.
113. Korc, M (2004) Update on diabetes mellitus. Dis. Markers 20: 161-165.
114. Lee, KC and Kraus, WL (2001) Nuclear receptors, coactivators and chromatin: new approaches, new insights. Trends Endocrinol. Metab. 12: 191-197.
115. Manger, WM and Eisenhofer, G (2004) Phaeochromocytoma: Diagnosis and management update. Curr. Hypertens. Rep. 6: 477-484.
116. Nadar, S, Lip, GYH and Beevers, DG (2003) Primary hyperaldosteronism. Ann. Clin. Biochem. 40: 439-452.
117. Roberts, CGP and Ladenson, PW (2004) Hypothyroidism. Lancet 363: 793-803.
118. Speiser, PW and White, PC (2003) Congenital adrenal hyperplasia. N. Engl. J. Med. 349: 776-788.
119. Stumvoll, M, Goldstein, BJ and van Haeften, TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346.
120. Sulak, PJ (2004) Oral contraceptive update: new agents and regimens. J. Fam. Pract. Suppl: S5-S12.
121. Taylor, A (2003) ABC of subfertility: Making a diagnosis. BMJ 327: 494-497.
122. Ten, S, New, M and Maclaren, N (2001) Addison's disease 2001. J. Clin. Endocrinol. Metab. 86: 2909-2933.
123. Topliss, DJ and Eastman, CJ (2004) Diagnosis and management of hyperthyroidism and hypothyroidism. Med. J. Aust. 180: 186-193.
124. Trachtenbarg, DE (2005) Diabetic ketoacidosis. Am. Fam. Physician 71: 1705-1714.
125. Verbalis, JG (2003) Diabetes insipidus. Rev. Endocr. Metab. Disord. 4: 177-185.
126. Verhelst, J and Abs, R (2003) Hyperprolactinemia: pathophysiology and management. Treat. Endocrinol. 2: 23-32.
127. Williams, M (1998) Disorders of the adrenal gland. Semin. Preoper. Nurs. 7: 179-185.
128. Andreoli, TE (2000) Water: normal balance, hyponatraemia and hypernatraemia. Ren. Fail. 22: 711-735.
129. Ariyan, CE and Sosa, JA (2004) Assessment and management of patients with abnormal calcium. Crit. Care Med. 32: S146-S154.
130. Costa, J, Crausman, RS and Weinberg, MS (2004) Acute and chronic renal failure. J. Am. Podiatr. Med. Assoc. 94: 168-176.
131. DiMeglio, LA, White, KE and Econs, MJ (2000) Disorders of phosphate metabolism. Endocrinol. Metab. Clin. North Am. 29: 591-609.
132. Fall, PJ (2000) Hyponatraemia and hypernatraemia: A systematic approach to causes and their correction. Postgrad. Med. 107: 75-82.
133. Fukagawa, M and Kurokawa, K (2002) Calcium homeostasis and imbalance. Nephron 92: 41-45.
134. Gennari, FJ (2002) Disorders of potassium homeostasis: Hypokalaemia and hyperkalaemia. Crit. Care Clin. 18: 273-288.
135. Inzucchi, SE (2004) Understanding hypercalcaemia. Its metabolic basis, signs and symptoms. Postgrad. Med. 115: 73-76.
136. Kapoor, M and Chan, GZ (2001) Fluid and electrolyte abnormalities. Crit. Care Clin. 17: 503-529.
137. Lamb, EJ, Tomson, CRV and Roderick, PJ (2005) Estimating kidney function in adults using formulae. Ann. Clin. Biochem. 42: 321-345.
138. Molitoris, BA (1999) Acute renal failure. Drugs Today 35: 659-666.
139. Pascual, E and Pedraz, T (2004) Gout. Curr. Opin. Rheumatol. 16: 282-286.
140. Rott, KT and Agudelo, CA (2003) Gout. J. Am. Med. Assoc. 289: 2857-2860.
141. Topf, JM and Murray, PT (2003) Hypomagnesemia and hypermagnesemia. Rev. Endocr. Metab. Disord. 4: 195-206.
142. Touyz, RM (2004) Magnesium in clinical medicine. Front. Biosci. 1: 1278-1293.
143. Yu, HT (2003) Progression of chronic renal failure. Arch. Intern. Med. 163: 1417-1429.
144. Allen, K (2005) Four-step method of interpreting arterial blood gas analysis. Nurs. Times 10: 42-45.
145. Fall, PJ (2000) A stepwise approach to acid-base disorders. Practical patient evaluation for metabolic acidosis and other conditions. Postgrad. Med. 107: 249-258.
146. Gluck, SL (1998) Acid-base. Lancet 352: 474-479.
147. Kraut, JA and Madias, NE (2001) Approach to patients with acid-base disorders. Respir. Care 46: 392-403.
148. Soleimani, M and Burnham, CE (2000) Physiologic and molecular aspects of the Na+: HCO3-cotransporter in health and disease processes. Kidney Int. 57: 371-384.
149. Soleimani, M and Burnham, CE (2001) Na+: HCO3-cotransporters (NBC): Cloning and characterization. J. Membr. Biol. 183: 71-84.
150. Whittier, WL and Rutecki, GW (2004) Primer on clinical acid-base problem solving. Dis. Mon. 50: 122-162.
151. Williamson, JC (1995) Acid-base disorders: classification and management strategies. Am. Fam. Physician 52: 584-590.
152. Astrup, A, Meinert Larsen, T and Harper, A (2004) Atkins and other lowcarbohydrate diets: hoax or an effective tool for weight loss? Lancet 364: 897-899.
153. Azzi, A and Zingg, J-M (2005) Vitamin E. Biochem. Mol. Biol. Edu. 33: 184-187.
154. Bartlett, MG (2003) Biochemistry of the water soluble vitamins: A lecture for first-year pharmacy students. Am. J. Pharm. Educ. 67: 64-67.
155. Bates, CJ (1999) Diagnosis and detection of vitamin deficiencies. Br. Med. Bull. 55: 643-657.
156. Bender, DA (2002) Introduction to Nutrition and Metabolism, Taylor and Francis, London, UK.
157. Castiglia, PT (1996) Protein-energy malnutrition (kwashiorkar and marasmus). J. Pediatr. Health Care 10: 28-30.
158. Fairfield, KM and Fletcher, RH (2002) Vitamins for chronic disease prevention in adults-Scientific review. J. Am. Med. Assoc. 287: 3116-3126.
159. Gardner, D (2003) The etiology of obesity. Mo. Med. 100: 242-246.
160. Geissler, C and Powers, HJ (2005) Human Nutrition. Churchill Livingstone, London, UK.
161. Hoek, HW and van Hoeken, D (2003) Review of the prevalence and incidence of eating disorders. Int. J. Eat. Disord. 34: 383-396.
162. Hollick, MF (2003) Vitamin D: a millennium perspective. J. Cell. Biochem. 88: 296-307.
163. Jackson, MJ (1999) Diagnosis and detection of micronutrients: minerals. Br. Med. Bull. 55: 634-642.
164. Klein, DA and Walsh, BT (2004) Eating disorders: clinical features and pathophysiology. Physiol. Behav. 81: 359-374.
165. Kopelman, PG and Grace, C (2004) New thoughts on managing obesity. Gut 53: 1044-1053.
166. Murphy, B and Manning, Y (2003) An introduction to anorexia nervosa and bulimia nervosa. Nurs. Stand. 18: 45-52.
167. Nicholls, D and Viner, R (2005) Eating disorders and weight problems. BMJ 330: 950-953.
168. Taubes, G (2001) The soft science of dietary fat. Science 291: 2536-2545.
169. Ten Cate, JM (2004) Fluorides in caries prevention and control: Empiricism or science. Caries Res. 38: 254-257.
170. Vermeer, G and Schurgers, LJ (2000) A comprehensive review of vitamin K and vitamin K antagonists. Hematol. Oncol. Clin. North. Am. 14: 339-345.
171. Bhatia, M, Wong, FL, Cao, Y, Lau, HY, Huang, J, Puneet, P and Chevali, L (2005) Pathophysiology of acute pancreatitis. Pancreatology 5: 132-144.
172. DiMagno, MJ and DiMagno, EP (2003) Chronic pancreatitis. Curr. Opin. Gastroenterol. 19: 451-457.
173. Gibril, F and Jensen, RT (2004) Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion. Curr. Gastroenterol. Reports 6: 454-463.
174. Higuchi, H and Gores, GJ (2003) Mechanisms of liver injury: an overview. Curr. Molec. Med. 3: 483-490.
175. Iredale, JP (2003) Cirrhosis: new research provides a basis for rational and targeted treatments. BMJ 327: 143-147.
176. Johnson, LR (2001) Gastrointestinal Physiology, 6th edn, Mosby, St Louis, USA.
177. Kagnoff, MF (2005) Overview and pathogenesis of celiac disease. Gastroenterology 128: S10-S18.
178. Karsan, HA, Rojter, SE and Saab, S (2004) Primary prevention of cirrhosis. Public health strategies that make a difference. J. Postgrad. Med. 115: 25-30.
179. Kashiwagi, H (2005) Ulcers and gastritis. Endoscopy 37: 110-115.
180. Kastin, DA and Buchman, AL (2002) Malnutrition and gastrointestinal disease. Curr. Opin. Gastroenterol. 18: 221-228.
181. Kingsnorth, A and O'Reilly, D (2006) Acute pancreatitis. BMJ 332: 1072-1076.
182. Limdi, JK and Hyde, GM (2003) Evaluation of abnormal liver function tests. Postgrad. Med. J. 79: 307-312.
183. Louw, JA and Marks, IN (2004) Peptic ulcer disease. Curr. Opin. Gastroenterol. 20: 533-537.
184. McKevith, B and Theobald, H (2005) Common food allergies. Nurs. Stand. 19: 39-42.
185. Pearson, C (2004) Inflammatory bowel disease. Nurs. Times 100: 86-90.
186. Pineiro-Carrero, VM and Pineiro, EO (2004) Liver. Pediatrics 113: 1097-1106.
187. Roche, SP and Kobos, R (2004) Jaundice in the adult patient. Am. Fam. Phys. 69: 299-304.
188. Ross, G (2003) Hyperbilirubinemia in the 2000s: what should we do next? Am. J. Perinatol. 20: 415-424.
189. Sachs, G, Weeks, DL, Melchers, K and Scott, DR (2003) The gastric biology of Helicobacter pylori. Ann. Rev. Physiol. 65: 349-369.
190. Small, CJ and Bloom, SR (2004) Gut hormones and the control of appetite. Trends Endocrinol. Metab. 15: 259-263.
191. Tack, J, Bisschops, R and Sarnelli, G (2004) Pathophysiology and treatment of functional dyspepsia. Gastroenterology 127: 1239-1255.
192. Tomer, G and Ahneider, BL (2003) Disorders of bile formation and biliary transport. Gastroenterol. Clin. N. Am. 32: 839-855.
193. Various authors (2005) The gut: inner tube of life. Science 307: 1895-1925.
194. Warren, BF (2004) Classic pathology of ulcerative and Crohn's colitis. J. Clin. Gastroenterol. 38: S33-S35.
195. Wilson, TR (2005) The ABCs of hepatitis. Nurse Pract. 30: 12-21.
196. Bartlett, D (2004) Acetaminophen toxicity. J. Emerg. Nurs. 30: 281-283.
197. Bellinger, DC (2004) Lead. Pediatrics 113: 1016-1022.
198. Furge, LL and Guengerich, FP (2006) Cytochrome P450 enzymes in drug metabolism and chemical toxicology. Biochem. Mol. Biol. Educ. 34: 66-74.
199. Geffreys, D (2005) Aspirin: the remarkable story of a wonder drug. Bloomsbury, London.
200. Greene, SL, Dargan, PI and Jones, AL (2005) Acute poisoning: understanding 90% of cases in a nutshell. Postgrad. Med. J. 81: 204-216.
201. Jarup, L (2003) Hazards of heavy metal contamination. Br. Med. Bull. 68: 167-182.
202. Jones, DEH and Ledingham, KWL (1982) Arsenic in Napoleon's Wallpaper. Nature 299: 626-627.
203. Kao, LW and Nanagas, KA (2004) Carbon monoxide poisoning. Emerg. Med. Clin. North. Am. 22: 985-1018.
204. Kennedy, NP and Tipton, KF (1990) Ethanol metabolism and alcoholic liver disease. Essays in Biochem. 25: 137-195.
205. Levesque, H and Lafont, O (2000) Aspirin throughout the ages: an historical review. Review de Medicine Interne, 21 Suppl 1:8s-17s.
206. Lieber, CS (2000) Alcoholism: its metabolism and interaction with nutrients. Annu. Rev. Nutr. 20: 395-430.
207. Mehta, P (2002) Aspirin in the prophylaxis of coronary artery disease. Curr. Opin. Cardiol. 17: 552-558.
208. Nadarajah, P and Hayden, MJ (2004) Poisoning. Hosp. Med. 65: 174-177.
209. National Poisons Information Service and Association of Clinical Biochemists (2002) Laboratory analyses for poisoned patients: joint position paper. Ann. Clin. Biochem. 39: 328-339.
210. Needleman, H (2004) Lead poisoning. Annu. Rev. Med. 55: 209-222.
211. Nelson, DR (1999) Cytochrome and the individuality of species. Arch. Biochem. Biophys. 369: 1-10.
212. Oremaland, RS and Stolz, JF (2003) The ecology of arsenic. Science 300: 939-944.
213. Ryter, SW and Otterbein, LE (2004) Carbon monoxide in biology and medicine. BioEssays 26: 270-280.
214. Scally, RD, Ferguson, DR, Piccaro, JC, Smart, ML and Archie, TE (2002) Treatment of ethylene glycol poisoning. Am. Fam. Physician 66: 807-812.
215. Song, Z, Joshi-Barve, S, Barve, S and McClain, CJ (2004) Advances in alcoholic liver disease. Curr. Gastroenterol. Rep. 6: 71-76.
216. Stachulski, AV and Lennard, MS (2000) Drug metabolism: the body's defence against chemical attack. J. Chem. Educ. 77: 349-353.
217. Stewart, S, Jones, D and Day, CP (2001) Alcoholic liver disease: new insights into mechanisms and preventative strategies. Trends Mol. Med. 7: 408-413.
218. Tchounwou, PB, Centeno, JA and Patlolla, AK (2004) Arsenic toxicity, mutagenesis, and carcinogenesis-a health risk assessment and management approach. Mol. Cell Biochem. 255: 47-55.
219. Underwood, M (2006) Diagnosis and management of gout. BMJ 332: 1315-1319.
220. Watson, I and Proudfoot, A (2002) Poisoning and Laboratory Medicine, ACB Venture Publications, London.
221. Yip, L, Dart, RC and Gabow, PA (1994) Concepts and controversies in salicylate toxicity. Emerg. Med. Clin. North. Am. 12: 351-364.
222. Bhagavan, NV (2002) Medical Biochemistry, 4th edn, Harcourt Academic Press, San Diego.
223. Campbell, K (2004) Pathophysiology of anaemia. Nurs.Times 100: 40-43.
224. Catlin, AJ (2003) Thalassemia: the facts and the controversies. Pediatr. Nurs. 29: 447-449.
225. Clark, BE and Thein, SL (2004) Molecular diagnosis of haemoglobin disorders. Clin. Lab. Haematol. 26: 159-176.
226. Claster, S and Vichinsky, EP (2003) Managing sickle cell disease. BMJ 327: 1151-1155.
227. Dame, C and Sutor, AH (2005) Primary and secondary thrombocytosis in childhood. Br. J. Haematol. 129: 165-177.
228. Dhaliwal, G, Cornett, PA and Tierney, LM (2004) Hemolytic anemia. Am. Fam. Physician 69: 2599-2606.
229. Gottlieb, S (2001) Gene therapy shows promise for haemophilia. BMJ 322: 1442.
230. Hoffbrand, AV and Pettit, JE (2002) Essential Haematology, 4th edn, Blackwell Science, Oxford.
231. Howard, MR and Hamilton, P (2002) Haematology. Churchill Livingstone, London.
232. Hughes-Jones, NC, Wickramsinghe, SN and Hatton, C (2004) Lecture Notes on Haematology, Blackwell Publishing, Oxford, UK.
233. Mannucci, PM and Tuddenham, EGD (2001) The hemophilias-from royal genes to gene therapy. New Engl. J. Med. 344: 1773-1779.
234. Mehta, A, Mason, PJ and Vulliamy, TJ (2000) Glucose-6-phosphate dehydrogenase deficiency. Baillière's Best Pract. Res. Clinical Haematol. 13: 21-38.
235. Potts, DM and Potts, WT (1999) Queen Victoria's Gene: Haemophilia and the Royal Family, 2nd edn. Sutton Publishing, NY.
236. Serjeant, GR (2005) Mortality from Sickle cell disease in Africa. BMJ 330: 432-433.
237. Stuart, MJ and Nagel, RL (2004) Sickle-cell disease. Lancet 364: 1343-1360.
238. Vidler, V (2004) Haemophilia. Br. J. Perioper. Nurs. 14: 110-113.
239. Wajeman, H and Galacteros, F (2005) Hemoglobins with high oxygen affinity leading to erythrocytosis. New variants and new concepts. Hemoglobin 29: 91-106.
240. Weatherall, DJ (2000) Single gene disorders or complex traits: lessons from the thalassaemias and other monogenic disorders. BMJ 321: 1117-1120.
241. Working Party of the General Haematology Task Force of the British Committee for Standards in Haematology (1998) The laboratory diagnosis of haemoglobinopathies. Br. J. Haematol. 101: 783-792.
242. Chalela, JA, Merino, JG and Warach, S (2004) Update on stroke. Curr. Opin. Neurol. 17: 447-451.
243. Chilton, RJ (2004) Pathophysiology of coronary heart disease: a brief review. J. Am. Osteopath Assoc. 104: S5-S8.
244. Choy, PC, Siow, YL and Mymin, DOK (2004) Lipids and atherosclerosis. Biochem. Cell Biol. 82: 212-214.
245. Fox, KF (2005) investigation and management of chest pain. Heart 91: 105-110.
246. Nicholas, M (2004) Heart failure: pathophysiology, treatment and nursing care. Nursing Stand. 19: 46-51.
247. Page, RL (2004) Clinical practice. Newly diagnosed atrial fibrillation. N. Engl. J. Med. 351: 2408-2416.
248. Rullan, F and Sigal, LH (2001) Rheumatic fever. Curr. Rheumatol. Rep. 3: 445-452.
249. Scott, J (2004) Pathophysiology and biochemistry of cardiovascular disease. Curr. Opin. Genet. Dev. 14: 271-279.
250. Torney, WT (1996) The diagnosis and management of acute myocardial infarction-a role for biochemical markers? Ann. Clin. Biochem. 33: 477-481.
251. Yee, CA (2005) Endocarditis: the infected heart. Nursing Manage. 36: 25-30.
252. Bahado-Singh, RO, Oz, U, Kovanci, E, Cermic, D, Flores, D, Copel, J, Mahoney, M and Cole, L (1998) New triple screen test for Down syndrome: combined urine analytes and serum AFP. J. Maternal-Fetal Med. 7: 111-114.
253. Caine, A, Maltby, AE, Parkin, CA, Waters, JJ and Crolla, JA (2005) Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment. Lancet 366: 123-128
254. Cederbaum, S (2002) Phenylketonuria: an update. Curr. Opin. Pediatrics 14: 702-706.
255. Chakraborty, C, Nandi, S and Jana, S (2005) Prion disease: a deadly disease for protein misfolding. Curr. Pharm. Biotechnol. 6: 167-177.
256. Clague, A and Thomas, A (2002) Neonatal biochemical screening for disease. Clin. Chim. Acta 315: 99-110.
257. Cockle, H (1999) Maternal age-standardisation of prevalence of Down's syndrome. Lancet 354: 529-530
258. DeArmond, SJ and Bouzamondo, E (2002) Fundamentals of prion biology and diseases. Toxicology 181-182: 9-16.
259. Kooy, RF, Willemsen, R and Oostra, BA (2000) Fragile X syndrome at the turn of the century. Molec. Med. Today 6: 193-198.
260. Lanfranco, F, Kamischke, A, Zitzmann, M and Nieschlag, E (2004) Klinefelter's syndrome. Lancet 364: 273-283.
261. Migeon, CJ and Wisniewski, AB (2003) Human sex differentiation and its abnormalities. Best Pract. Res. Clin. Obst. Gynaecol. 17: 1-18.
262. Nativio, DG (2002) The genetics, diagnosis and management of Prader-Willi syndrome. J. Ped. Health Care 16: 298-303.
263. Parmar, S and Tallman, MS (2003) Acute promyelocytic leukaemia: a review. Expert Opin. Pharmacotherapy 4: 1379-1392.
264. Patterson, GD (1987) The causes of Down syndrome. Sci. Am. 257 (1): 52-61.
265. Roizen, NJ and Patterson, D (2003) Down's syndrome. Lancet 361: 99-110.
266. Schafer, AJ (1996) Sex determination in humans. BioEssays 18: 955-963.
267. Scrivener, CR, Beaudet, AL, Sly, WS, Valle, D, Kinzler, KW and Vogelstein, B (eds) (2001) The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, NY.
268. Stankiewicz, P and Lupski, JR (2002) Genomic architecture, rearrangements and genetic disorders. Trends Gen. 18: 74-82.
269. Sybert, VP and McCauley, E (2004) Turner's syndrome. New Engl. J. Med. 351: 1227-1238.
270. Taylor, AI (1968) Autosomal trisomy syndromes: A detailed study of 27 cases of Edwards syndrome and 27 cases of Patau syndrome. J Med. Gen. 5: 227-252.
271. Terracciano, A, Chiurazzi, P and Neri, G (2005) Fragile X syndrome. Am. J. Med. Gen. 137C: 32-37.
272. Wattendorf, DJ and Muenke, M (2005) Diagnosis and management of fragile X syndrome. Am. Fam. Phys. 72: 111-113.
273. Chinnery, PF and Turnbull, DM (2001) Epidemiology and treatment of mitochondrial disorders. Am. J. Med. Genet. 106: 94-101.
274. Cronshaw, JM and Matunis, MJ (2004) The nuclear pore complex: disease associations and functional correlations. Trends Endocrinol. Metab. 15: 34-39.
275. Delaunay, J (2002) Molecular basis of red cell membrane disorders. Acta Haematol. 108: 210-218.
276. DiMauro, S (2004) Mitochondrial diseases. Biochim. Biophys. Acta 1658: 80-88.
277. DiMauro, S and Schon, EA (2001) Mitochondrial DNA mutations in human disease. Am. J. Med. Genet. 106: 18-26.
278. Emery, AEH (2002) Muscular dystrophy into the new millennium. Neuromuscul. Disord. 12: 343-349.
279. Fahrenkrog, B, Köser, J and Aebi, U (2004) The nuclear pore complex: a jack of all trades? Trends Biochem. Sci. 29: 175-182.
280. Futerman, AH, Sussman, JL, Horowitz, M, Silman, I and Zimran, A (2004) New directions in the treatment of Gaucher disease. Trends Pharmacol. Sci. 25: 147-151.
281. Gabriel, SE, Brigman, KN, Koller, BH, Boucher, RC and Stutts, MJ (1994) Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266: 107-109.
282. Gieselmann, V, Matzner, U, Klein, D, Mansson, JE, D'Hooge, R, DeDeyn, PD, Rauch, RL, Hartmann, D and Harzer, K (2003) Gene therapy: Prospects for glycolipid storage diseases. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 358: 921-925.
283. Goldfarb, DS, Corbett, AH, Mason, DA, Harreman, MT and Adam, SA (2004) Importin: a multipurpose nuclear-transport receptor. Trends Cell Biol. 14: 505-514.
284. Hancock, MR (2002) Mitochondrial dysfunction and the role of the nonspecialist laboratory. Ann. Clin. Biochem. 39: 456-463.
285. Hyde, SC, Gill, DR, Higgins, CF and Trezise, EO (1993) Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362: 250-255.
286. McGuinness, MC, Wei, HM and Smith, KD (2000) Therapeutic developments in peroxisome biogenesis disorders. Expert Opin. Investig. Drugs 9: 1985-1992.
287. Ratjen, F and Doring, G (2003) Cystic fibrosis. Lancet 361: 681-689.
288. Schwarz, MJ (1998) DNA diagnosis of cystic fibrosis. Ann. Clin. Biochem. 35: 584-610.
289. Towbin, JA (1998) The role of cytoskeletal proteins in cardiomyopathies. Curr. Opin. Cell Biol. 10: 131-139.
290. Wanders, RJA (2004) Metabolic and molecular basis of peroxisomal disorders: a review. Am. J. Med. Genet. 126A: 355-375.
291. Wenger, DA, Coppola, S and Liu, SL (2002) Lysosomal storage disorders: diagnostic dilemmas and prospects for therapy. Gen. Med. 4: 412-419.
292. Yashiroda, Y and Yoshida, M (2003) Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs. Curr. Med. Chem. 10: 741-748.
293. Yew, NS and Cheng, SH (2001) Gene therapy for lysosomal storage disorders. Curr. Opin. Mol. Ther. 3: 399-406.
294. Bhurani, D and Gottlieb, D (2004) The chronic leukaemias http://www.australiandoctor.com.au
295. Caldas, C (1998) Molecular assessment of cancer. BMJ 316: 1360-1363.
296. Cooperberg, MR, Moul, JW and Carrol, PR (2005) The changing face of prostate cancer. J. Clin. Oncol. 10: 8146-8151.
297. Doll, R (2000) Smoking and Lung Cancer. Am. J. Crit. Care Med. 162: 4-6.
298. Donaldson, MS (2004) Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr. J. 3: 19-40.
299. El-Deiry, WS (2005) Colon cancer, adenocarcinoma. http://www.emedicine.com
300. Flaitz, CM and Hicks, MJ (1998) Molecular Piracy: the viral link to carcinogenesis. Oral Oncol. 34: 448-453.
301. Futreal, PA, Coin, L, Marshall, M, Down, T, Hubbard, T, Wooster, R, Rahman, N and Stratton, MR (2004) A census of human cancer genes. Nat. Rev. Cancer 4: 177-183.
302. Garland, CF, Garland, FC, Gorham, ED, Lipkin, M, Newmark, H, Sharif, BM and Holick, MF (2006) The role of vitamin D in cancer prevention. Am. J. Public Health 96: 252-261.
303. Giordano, SH, Cohen, DS, Buzdar, AU, Perkins, G and Hortobagyi, GN. (2004) Breast cancer in men: A population-based study. Cancer 101: 51-57.
304. Hoffbrand AV, Petit JE and Moss PAH (2001) Essential Hematology. 4th edn. Blackwell Science, Malden, MA.
305. Horig, H, Medina, FA, Conkright, WA and Kaufman, HL (2000) Strategies for cancer therapy using carcinoembryonic antigen vaccines. Exp. Rev. Molec. Med. 2000: 1-24.
306. Jones, GR (2003) Li-Fraumeni syndrome. http://www.emedicine.com
307. King, JBR and Robins, M (2006) Cancer Biology. Prentice-Hall Ltd, Harlow, UK.
308. Latonen, L and Laiho, M (2005) Cellular UV damage responses-Functions of tumor suppressor p53. Biochim. Biophys. Acta 1755: 71-89.
309. Liesner, RJ and Goldstone, AH (1997) ABC of clinical haematology: the acute leukaemias. BMJ 314: 733-736.
310. Office for National Statistics (2005) Cancer statistics registration: Registrations of cancer diagnosed in 2002, England. Crown Copyright 2005. Also at http://www.statistics.gov.uk
311. Radtke, F and Clevers, H (2005) Self-renewal and cancer to the gut: Two sides of a coin. Science 307: 1904-1909.
312. Ries, LAG, Eisner, MP, Kosary, CL, Hankey, BF, Miller, BA, Clegg, L, Mariotto, A, Feuer, EJ and Edwards, BK (eds). SEER Cancer Statistics Review, 1975-2002, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER web site 2005.
313. Tisdale, MJ (2005) Molecular pathways leading to cancer cachexia. Physiology 20: 340-348.
314. Turnbull, C and Hodgson, S (2005) Genetic predisposition to cancer. Clin. Med. 5: 491-498.
315. Uauy, R and Solomons, N (2005) Diet, nutrition and the life-course approach to cancer prevention. J. Nutr. 135: 2934S-2945S.
316. Various authors (2001) Nature 411: 335-396. Contains a series of articles on cancer.
317. von Meyenfeldt, M (2005) Cancer-associated malnutrition: an introduction. Eur. J. Oncol. Nurs. 9: S33-S38.
318. Wallis, G (1999) The Genetic Basis of Human Disease. The Biochemical Society, London. http://www.biochemistry.org/
319. Yuspa, SH (2000) Overview of carcinogenesis: past, present and future. Carcinogenesis 21: 341-344.
320. Cummings, JL (2004) Alzheimer's disease. N. Engl. J. Med. 351: 56-67.
321. Fisher, GJ, Kang, S, Varani, J, Bata-Csorgo, Z, Wan, Y, Dhatta, S and Voorhees, JJ (2002) Mechanisms of photoaging and chronological skin aging. Arch. Dermatol. 138: 1463-1470.
322. Kipling, D, Davis, T, Ostler, EL and Faragher, RGA (2004) What can progeroid syndromes tell us about human aging? Science 305: 1426-1431.
323. Kirkwood, TB (2005) Understanding the odd science of aging. Cell 120: 437-447.
324. Kirkwood, TBL and Austad, SN (2000) Why do we age? Nature 408: 233-238.
325. Koubova, J and Guarente, L (2003) How does calorie restriction work? Genes Dev., 17: 313-321.
326. Marks, R (1999) Spotlight on solar elastosis. Retinoids 15: 6-10.
327. Pollex, RL and Hegele, RA (2004) Hutchinson-Gilford progeria syndrome, Clin. Genet. 66: 375-381.
328. Robert, L and Robert, AM (2003) Aging, from basic research to pathological applications. Pathol. Biol. 51: 543-549.
329. Sarkar, PK and Shinton, RA (2001) Hutchinson-Guildford progeria syndrome. Postgrad. Med. J. 77: 312-317.
330. Selkoe, DJ (2001) Alzheimer's disease: genes, proteins and therapy. Physiol. Rev. 81: 741-766.
331. Spence, AP (1999) Biology of Human Aging, Prentice Hall, New Jersey, USA.
332. Weindruch, R and Sohal, RS (1997) Calorie intake and aging, N. Engl. J. Med. 337: 986-994.
333. Weinhert, BT and Timiras, PS (2003) Theories of aging. J. Appl. Physiol. 95: 1706-1716.